Struggling with severe Type 2 Diabetes? China is pioneering Regenerative Islet Transplantation (E-islet) with dual US-China IND approvals.
As a dedicated medical concierge provider, MedBridgeNZ coordinates your entire healthcare journey to top-tier Chinese hospitals. We don't provide medical advice, but we do provide seamless logistical access.
Read the clinical guide & request a free case review:https://zurl.co/wldVW
#MedicalTourismChina #Type2Diabetes #RegenerativeMedicine #HealthLogistics

Is Regenerative Islet Transplantation in China Right for You?
Home > Blog > Advanced Therapies & TechnologyKey Takeaways • Type 2 Diabetes Mellitus (T2DM) management in China has shifted from simple glycemic control to a comprehensive metabolic strategy, encompassing multi-target pharmacotherapy, metabolic surgery, and regenerative medicine. • Novel regenerative islet transplantation (E-islet) utilizing endoderm-directed stem cells has demonstrated sustained insulin independence in clinical trials, earning dual Investigational New Drug (IND) approvals fr
